Is a complete FMS research report available?

No complete published report is available for Fresenius Medical Care AG (FMS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FMS Stock Analysis, Forecast & Valuation

Market cap	13.1B
Revenue (ttm)	22.3B
Net income (ttm)	1.1B
EPS (ttm)	$3.80
Shares out	268.6M
P/E (trailing)	12.0x
P/E (forward)	39.0x
Dividend	$0.61 (2.45%)
Volume	1,263,871

Beta	0.82

Price target	$25.6	+3.4%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All FMS indicators

Market & fundamental data

Available fields

274

Groups with data

Currency

EUR

Showing 274 of 274 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001333141
Company name	Fresenius Medical Care AG
Country	Germany
Country code	US
Cusip	358029106
Employees	109,698
Employees Change	-1,815%
Employees Change Percent	-1.63
Enterprise value	$25.3B
Exchange	NYSE
Financial currency	EUR
First seen	2026-05-09
Industry	Medical Care Facilities
Industry PE	16.17
Industry PE Fwd	15.24
IPO Date	1996-09-19
Isin	US3580291066
Last refreshed	2026-07-29
Market cap	$13.1B
Market cap category	Large-Cap
Price	$24.75
Price currency	USD
Rev Per Employee	203,469.37x
Sector	Healthcare
Sector PE	45.13
Sector PE Fwd	23.9
Sic	8090
Symbol	FMS
Website	https://www.freseniusmedicalcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.33%
EV Earnings	23.27x
EV Sales Forward	1.35x
EV/EBIT	14.88x
EV/EBITDA	7.26x
EV/FCF	12.47x
EV/Sales	1.14x
FCF yield	15.54%
Forward P/E	38.96x
P/B ratio	0.8x
P/E ratio	12.01x
P/S ratio	0.59x
PE Ratio10 Y	18.03x
PE Ratio3 Y	19.76x
PE Ratio5 Y	18.78x
PS Forward	0.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.73%
EBITDA Margin	15.83%
FCF margin	9.22%
Gross margin	25.95%
Gross Profit	$5.8B
Gross Profit Growth	5.4%
Gross Profit Growth Q	-0.38%
Gross Profit Growth3 Y	1.05%
Gross Profit Growth5 Y	-1.27%
Net Income	$1.1B
Net Income Growth	52.82%
Net Income Growth Q	-22.28%
Net Income Growth Years	2%
Net Income Growth3 Y	16.18%
Net Income Growth5 Y	-3.53%
Pretax Margin	7.59%
Profit Margin	4.88%
Profit Per Employee	$9,929
Profitable Quarters	$85
Profitable Years	23
ROA	3.63
Roa5y	3.11
ROCE	5.97
ROE	7.85
Roe5y	6.59
ROIC	6.25
Roic5y	4.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.3%
Cagr15y	-1.67%
Cagr1y	-3.74%
Cagr20y	2.37%
Cagr3y	0.18%
Cagr5y	-7.47%
Div CAGR10	6.85%
Div CAGR3	13.44%
Div CAGR5	-10.75%
EPS Growth	56.34
EPS Growth Q	-17.15
EPS Growth Years	2
EPS Growth3 Y	17.13
EPS Growth5 Y	-3.13
FCF Growth	4.38%
FCF Growth Q	115.78%
FCF Growth3 Y	7.24%
FCF Growth5 Y	-9.26%
OCF Growth	13.36%
OCF Growth Q	39.35%
OCF Growth10 Y	6.29%
OCF Growth3 Y	8.46%
OCF Growth5 Y	-6.57%
Revenue Growth	-0.69x
Revenue Growth Q	-5.52x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.33x
Revenue Growth5 Y	1.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.6
Assets	$36.3B
Cash	$1.4B
Current Assets	$9.2B
Current Liabilities	$7.7B
Debt	$12.7B
Debt EBITDA	$3.65
Debt Equity	$0.78
Debt FCF	$6.26
Equity	$16.4B
Interest Coverage	3.87
Liabilities	$19.9B
Long Term Assets	$27.1B
Long Term Liabilities	$12.2B
Net Cash	$-11.3B
Net Cash By Market Cap	$-86.44
Net Debt EBITDA	$3.24
Net Debt Equity	$0.69
Net Debt FCF	$5.56
Tangible Book Value	$-2.1B
Tangible Book Value Per Share	$-7.95
WACC	5.8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.2
Inventory Turnover	6.54
Net Working Capital	$2.9B
Quick ratio	0.74
Working Capital	$1.6B
Working Capital Turnover	$11.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.31%
Dividend Growth	6.38%
Dividend Growth Years	2%
Dividend per share	$0.61
Dividend Years	28
Dividend Yield	2.45%
Ex Div Date	2026-05-22
Last Dividend	$0.61
Payout Frequency	Annual
Payout Ratio	15.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-35.55%
1Y total return	-3.74%
200-day SMA	23.42
3Y total return	0.53%
50-day SMA	23.05
50-day SMA vs 200-day SMA	50under200
5Y total return	-32.17%
All Time High	57.94
All Time High Change	-57.28%
All Time High Date	2018-01-31
All Time Low	3.35
All Time Low Change	638.81%
All Time Low Date	2002-09-19
ATR	0.42
Beta	0.82
Ch YTD	3.9
High	24.82
High52	27.64
High52 Date	2025-10-09
High52ch	-10.46%
Low	24.49
Low52	20.02
Low52 Date	2026-05-05
Low52ch	23.63%
Ma50ch	7.37%
Premarket Change Percent	-1.57
Premarket Price	$24.48
Premarket Volume	11,509
Price vs 200-day SMA	5.7%
RSI	63.35
RSI Monthly	53.33
RSI Weekly	61.09
Sharpe ratio	-0.12x
Sortino ratio	0.03
Total Return	4.76%
Tr YTD	6.81
Tr15y	-22.35%
Tr1m	6.5%
Tr1w	0.28%
Tr3m	12.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Ratings	Hold
Earnings EPS Estimate	$0.64
Earnings EPS Estimate Growth	23.08
Earnings Revenue Estimate	5,720,000,000x
Earnings Revenue Estimate Growth	7.59x
Operating Income	$2.1B
Operating Income Growth	19.5
Operating Income Growth Q	-1.62
Operating Income Growth3 Y	7.14
Operating Income Growth5 Y	-4.05
Operating margin	9.63
Price target	$25.6
Price Target Change	$3.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	181,394,247%
Float Percent	67.54%
Net Borrowing	241,717,838.9
Shares Insiders	0.04%
Shares Institutions	48.41%
Shares Out	268,564,630
Shares Qo Q	-3.73%
Shares Yo Y	-2.31%
Short Ratio	4.51
Short Shares	0.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	610,943.15x
Bv Per Share	56.53
CAPEX	$-1.1B
Ch10y	-44.8
Ch15y	-36.35
Ch1m	6.5
Ch1w	0.28
Ch1y	-6.36
Ch20y	23.78
Ch3m	9.42
Ch3y	-6
Ch5y	-38.72
Ch6m	10.39
Change	-0.48%
Change From Open	1.06
Close	24.87
Days Gap	-1.53
Depreciation Amortization	829,494,798.1
Dollar Volume	31,280,807.3
Earnings Date	2026-08-04
Earnings Time	bmo
EBIT	$1.7B
EBITDA	$3.5B
EPS	$3.8
F Score	7
FCF	$2B
FCF EV Yield	8.02x
FCF Per Share	$7.57
Financing CF	-1,960,688,343
Fiscal Year End	December
Founded	1,996
Goodwill	15,765,391,810.7
Graham Number	37.91185
Graham Upside	53.18
Income Tax	$349M
Investing CF	-903,687,305
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2012-12-04
Last Split Type	Forward
Last10k Filing Date	2026-02-24
Lynch Fair Value	$10.31
Lynch Upside	-58.36
Ma150	22.95
Ma150ch	7.83%
Ma20	24.06
Ma20ch	2.86%
Net CF	185,006,341
Next Earnings Date	2026-08-04
Open	24.49
Optionable	Yes
P FCF Ratio	6.43
P OCF Ratio	4.18
Payment Date	2026-06-08
Position In Range	78.79
Post Close	24.75
Postmarket Change Percent	0.04
Postmarket Price	$24.76
Ppne	7,336,582,244.3
Pre Close	24.87
Price Date	2026-07-28
Price EBITDA	$3.75
Relative Volume	2.07x
Revenue	22,320,183,322x
Tax By Revenue	1.56x
Tax Rate	20.6%
Tr20y	59.7%
Tr6m	13.48%
Volume	1,263,871
Z Score	1.84

Fresenius Medical Care AG (FMS)

Coverage state: Market snapshot only — no published research

Generate the first FMS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · FMS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FMS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FMS

Frequently asked questions